DocWire News Editors

DocwireNews

Researchers from the Mayo Clinic have developed a new artificial intelligence (<a href="https://www.docwirenews.com/condition-center/orthopedicscc/can-ai-predict-hip-fracture/">AI</a>)-based approach to screening for hypertrophic cardiomyopathy.The research team, publishing in the <a href="http://www.onlinejacc.org/content/75/7/722">Journal of the American College of Cardiology</a>, developed a convolutional neural network (CNN) that was validated using 12-lead electrocardiograms (ECGs) from 2,448 patients with verified diagnoses of hypertrophic cardiomyopathy (as well as more than 51,000 age- and sex-matched cohorts without hypertrophic cardiomyopathy). They looked particularly for the ability of the CNN to detect hypertrophic cardiomyopathy, and then proceeded to test it on another cohort of patients (612 patients with hypertrophic cardiomyopathy and 12,788 controls).According to the study results, the area under curve (AUC) of the CNN in the validation dataset was 0.95 (95% CI, 0.94 to 0.97) at the optimal probability threshold of 11% for having hypertrophic cardiomyopathy. When the 11% probability threshhold was applied to the testing dataset, the AUC for the CNN was 0.96, indicating a strong ability to detect patients with hypertrophic cardiomyopathy.&ldquo;The good performance in patients with a normal ECG is fascinating,&rdquo; Peter Noseworthy. MD, a study author and cardiologist at the Mayo Clinic, said in a <a href="https://newsnetwork.mayoclinic.org/discussion/mayo-researchers-create-test-ai-to-improve-ekg-testing-for-hypertrophic-cardiomyopathy/">press release</a>. &ldquo;It&rsquo;s interesting to see that even a normal ECG can look abnormal to a convolutional neural network. This supports the concept that these networks find patterns that are hiding in plain sight.&rdquo;When testing the AI subgroups, the reserachers looked at a group diagnosed with left ventricular hypertrophy. The CNN AUC for detection of this condition was 0.95. The AUC for the subgroup with normal ECGs was also 0.95. For aortic stenosis, the AUC was 0.94.&ldquo;This is a promising proof of concept, but I would caution that, despite its powerful performance, any screening test for a relatively uncommon condition is destined to have high false positive rates and low positive predictive value in a general population,&rdquo; Konstantinos Siontis, MD, co-author on the study and a cardiologist at Mayo Clinic, added. &ldquo;We still need to better understand which particular populations will benefit from this test as a screening tool.&rdquo;<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
<a href="https://twitter.com/hashtag/ECG?src=hash&amp;ref_src=twsrc%5Etfw">#ECG</a> read by Artificial Intelligence: is this the future of hypertrophic <a href="https://twitter.com/hashtag/cardiomyopathy?src=hash&amp;ref_src=twsrc%5Etfw">#cardiomyopathy</a> (HCM) detection? Dr. <a href="https://twitter.com/noseworthypeter?ref_src=twsrc%5Etfw">@noseworthypeter</a> and <a href="https://twitter.com/MayoClinic?ref_src=twsrc%5Etfw">@MayoClinic</a> colleagues develop an <a href="https://twitter.com/hashtag/AI?src=hash&amp;ref_src=twsrc%5Etfw">#AI</a> approach for HCM screening based on 12-lead electrocardiography in the latest <a href="https://twitter.com/hashtag/JACC?src=hash&amp;ref_src=twsrc%5Etfw">#JACC</a>. <a href="https://t.co/hZeIv94HNY">https://t.co/hZeIv94HNY</a> <a href="https://t.co/zy39feDMxG">pic.twitter.com/zy39feDMxG</a>
&mdash; JACC Journals (@JACCJournals) <a href="https://twitter.com/JACCJournals/status/1229798535022960646?ref_src=twsrc%5Etfw">February 18, 2020</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>http://twitter.com/J_Design328/statuses/1229880691900309505<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
99% Negative predictive value in excluding <a href="https://twitter.com/hashtag/HCM?src=hash&amp;ref_src=twsrc%5Etfw">#HCM</a>: excellent screening capability for <a href="https://twitter.com/hashtag/AI?src=hash&amp;ref_src=twsrc%5Etfw">#AI</a> -based ECG reading <a href="https://t.co/0blZkuB74D">https://t.co/0blZkuB74D</a>
&mdash; Santo Dellegrottaglie (@SantoDellegrot1) <a href="https://twitter.com/SantoDellegrot1/status/1229908690884579328?ref_src=twsrc%5Etfw">February 18, 2020</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script><blockquote class="twitter-tweet" data-width="500" data-dnt="true">
ECG-based detection of HCM by an AI algorithm can be achieved with high diagnostic performance, particularly in younger patients. &#128279;<a href="https://t.co/p6RV9bG0wF">https://t.co/p6RV9bG0wF</a> <a href="https://t.co/mpl1AcE7UW">pic.twitter.com/mpl1AcE7UW</a>
&mdash; Vicente Pallares (@vic_pallares) <a href="https://twitter.com/vic_pallares/status/1230006021390786562?ref_src=twsrc%5Etfw">February 19, 2020</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>&nbsp;

Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Jeffrey Perl, MD

Joel M. Topf, MD, FACP

Thoughts From the 2025 Lazarus Award Winner

NKF Spring Clinical Meetings 2025

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

Latest News

Using AI, ECGs May Soon Be Able to Screen for Hypertrophic Cardiomyopathy

Cardiology

Researchers from the Mayo Clinic have developed a new artificial intelligence (AI)-based approach to screening for hypertrophic cardiomyopathy. ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe